X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Testing for 63 Gene Variants Identifies Elevated Risk for Prostate Cancer

A transatlantic team of scientists led by the London-based Institute of Cancer Research (ICR) has made a major step towards the development of such a [genetic] test. They identified 63 new genetic variants that increase the risk of prostate cancer. By combining those variants with 100 others that had previously been identified as culprits in prostate cancer, they were able to identify men who are six times more likely to develop the disease because of inherited risk, according to a statement.

Read more. 

source: Arlene Weintraub - Fierce Biotech